Enumeration and Function Analysis of Treg Cells in Peripheral Blood of HCC Patients Before and After Ablation Therapy
NCT01668381 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2013-02-21
Summary
The purpose of this study is to determine the enumeration and function changes of regulatory t cells in peripheral blood of hepatocellular carcinoma patients before and 1 week, 4 weeks after ablation therapy.
Conditions
Interventions
- PROCEDURE
-
radiofrequency ablation
the patients are prepared by local anesthesia and intravenous sedative.guided by the ultrasound,the antenna used for radiofrequency ablation ablation is placed in the tumor to destroy tumor tissues,the output power and duration are depended by the tumor volume and location.
Sponsors & Collaborators
-
Guangdong Province, Department of Science and Technology
collaborator OTHER_GOV -
First Affiliated Hospital, Sun Yat-Sen University
lead OTHER
Principal Investigators
-
Ming Kuang, MD,PhD · First Affiliated Hospital, Sun Yat-Sen University
-
Qing-qi Ren, Bachelor · First Affiliated Hospital, Sun Yat-Sen University
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-08-31
- Primary Completion
- 2013-12-31
- Completion
- 2013-12-31
Countries
- China
Study Locations
More Related Trials
-
The Clinical Significance of Peripheral Blood T Lymphocyte PD-1 Expression and T Cell Subset Distribution.
NCT06029829 ·Status: UNKNOWN ·Phase: PHASE2
-
Clinical Efficacy and Safety of NKT Cell Infusion in Patients With Advanced Solid Tumor
NCT02562963 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Safety and Efficiency of γδ T Cell Against Non Small Lung Cancer ( Without EGFR Mutation)
NCT02425748 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Induced-T Cell Like NK Cellular Immunotherapy for Cancer Lack of MHC-I
NCT03882840 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Cytokine Regulation of Natural Killer Receptors in Inhibiting Activated T Cell Function
NCT00173290 ·Status: UNKNOWN
-
Immunotherapy Using Precision T Cells Specific to Personalized Neo-antigen for the Treatment of Advanced Malignant Tumor of Biliary Tract
NCT02632019 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
The Healthy Human Global Project - Hong Kong (HHGP-Hong Kong)
NCT05174624 ·Status: COMPLETED
-
Dendritic Cell Vaccination to Prevent Hepatocellular Carcinoma Recurrence After Liver Resection-phase II Clinical Trial
NCT06193733 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
T Regulatory Lymphocytes (Treg) Depletion for Cancer Treatment Efficacy and Safety Study
NCT00986518 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Study of Targeted NY-ESO-1 T Cell Receptor (TCR) Genetic Modified Autologous T Cells Treatment of Advanced Solid Tumors
NCT03047811 ·Status: UNKNOWN ·Phase: NA
-
Sequencing T-cells in Type I Diabetes Mellitus
NCT02040337 ·Status: COMPLETED
-
The Effects of Upper Airway and Digestive Tract Tumors on the Immune System
NCT00001603 ·Status: COMPLETED
-
Autologous Natural Killer T Cells Infusion for the Treatment of Cancer
NCT01801852 ·Status: UNKNOWN ·Phase: NA
-
Study of Autologous Immune Killer Cells in Patients With Late Stage Hepatocellular Carcinoma or Lung Cancer
NCT03515252 ·Status: COMPLETED ·Phase: PHASE1
-
TCR-T Cell Immunotherapy of Lung Cancer and Other Solid Tumors
NCT03778814 ·Status: RECRUITING ·Phase: PHASE1
-
Serum Immunological Profiles in Head and Neck Cancer Patients Receiving Curative Radiotherapy
NCT03325036 ·Status: COMPLETED
-
Autologous Neoantigen-Specific T-Cell Therapy for Advanced Hepatocellular Carcinoma
NCT07123545 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
NKG2D-CAR-NK92 Cells Immunotherapy for Solid Tumors
NCT05528341 ·Status: RECRUITING ·Phase: PHASE1
-
Universal Dual-target NKG2D-NKp44 CAR-T Cells in Advanced Solid Tumors
NCT05976906 ·Status: UNKNOWN ·Phase: PHASE1
-
Efficacy of Low Dose, SubQ Interleukin-2 (IL-2) to Expand Endogenous Regulatory T-Cells in Liver Transplant Recipients
NCT02739412 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II Study of TAEST16001 in Soft Tissue Sarcoma
NCT05549921 ·Status: RECRUITING ·Phase: PHASE2
-
Study of Polyfunctionality of Anti-tumor T Lymphocytes in Cancerology: Potential Biomarker for Emerging Immunotherapies
NCT02880046 ·Status: UNKNOWN
-
a Single-arm, Single-center, Open Clinical Study
NCT06431100 ·Status: RECRUITING
-
The Role of Regulatory T Cell in Ovarian Cancer: Focus on Relationship Between Clinical Prognosis and Regulatory T Cell Expression
NCT00854282 ·Status: UNKNOWN ·Phase: NA
-
CX3CR1+T Cell Predict Immunotherapy Efficacy
NCT06054152 ·Status: COMPLETED